1. SAT0096 Gastrointestinal tolerability in primary care patients treated with naproxen or rofecoxib for osteoarthritis (oa): the advantage trial. (1st June 2001) Authors: Geba, GP; Lisse, JR; Perlman, M; Polis, AB; Dixon, ME; Skalky, CS; Dobbins, T; Johansson, G; Shoemaker, JR; Schechtman, J; Mollen, AJ Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0058 Effects of baricitinib on patients who stop methotrexate monotherapy and switch to baricitinib monotherapy. (15th June 2017) Authors: Fleischmann, R; Takeuchi, T; Schiff, M; Schlichting, D; Xie, L; Issa, M; Stoykov, I; Lisse, JR; Martinez-Osuna, P; Rooney, T; Zerbini, CA Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 789 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0783 The relationship between the degree of skin involvement and joint activity in patients with psa: experience from the corrona registry. (15th June 2017) Authors: Mease, PJ; Etzel, CJ; Lisse, JR; Armstrong, AW; Huster, WJ; Rebello, S; Dodge, R; Muram, T; Al, S Sawah-Folian; Murage, MJ; Greenberg, JD; Malatestinic, W Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗